share_log

Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Recursion Pharmaceuticals | 144:擬議出售證券
美股sec公告 ·  06/28 05:13
牛牛AI助理已提取核心訊息
Recursion Pharmaceuticals, Inc. officer, Marriott Tina, is set to sell 6,000 Class A shares on 06/27/2024, as per the latest filing. The shares, valued at an aggregate market value of $43,290.18, were originally acquired on the same date through options granted on 07/23/2018. The transaction will be conducted in cash. This sale follows a recent history of transactions by Marriott Tina, who sold a total of 6,000 shares over the past three months, generating total gross proceeds of $49,345.50.
Recursion Pharmaceuticals, Inc. officer, Marriott Tina, is set to sell 6,000 Class A shares on 06/27/2024, as per the latest filing. The shares, valued at an aggregate market value of $43,290.18, were originally acquired on the same date through options granted on 07/23/2018. The transaction will be conducted in cash. This sale follows a recent history of transactions by Marriott Tina, who sold a total of 6,000 shares over the past three months, generating total gross proceeds of $49,345.50.
根據最新的文件,Recursion Pharmaceuticals, Inc. 的執行官Marriott Tina打算在2024年06月27日賣出6000股A類股份。這些股份的市場總價值爲43290.18美元,最初是通過2018年07月23日授予的期權獲得的。此次交易將以現金方式進行。在過去的三個月中,Marriott Tina 進行了多次交易,總共賣出了6000股,總毛收入爲49345.50美元。
根據最新的文件,Recursion Pharmaceuticals, Inc. 的執行官Marriott Tina打算在2024年06月27日賣出6000股A類股份。這些股份的市場總價值爲43290.18美元,最初是通過2018年07月23日授予的期權獲得的。此次交易將以現金方式進行。在過去的三個月中,Marriott Tina 進行了多次交易,總共賣出了6000股,總毛收入爲49345.50美元。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生,只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。